Navigation Links
Research on antibiotics receives historical recognition

Research leading to the discovery of streptomycin ?the first effective pharmaceutical treatment for tuberculosis ?will be designated a National Historic Chemical Landmark at Rutgers University in a special ceremony in New Brunswick, New Jersey, on May 24. The American Chemical Society, the world's largest scientific society, sponsors the landmarks program.

Beginning in the 1930s, Selman Waksman, Ph.D., and his students began the search for antibiotics produced from actinomycetes, microbes in the soil that are related to bacteria and fungi. The culmination was the isolation of streptomycin in 1943 by Albert Schatz, a graduate student of Waksman's, using soil screening methods developed by Waksman. This deliberate search for chemotherapeutic agents contrasts with the discovery of penicillin, which came through a chance observation by Alexander Fleming, who noted that a mold contaminant on a Petri dish culture had inhibited the growth of bacteria.

Streptomycin was the third antimicrobial agent isolated under Waksman's direction at Martin Hall at Cook College, Rutgers University. Streptomycin, however, was the first agent not toxic to humans, and it attacked a type of bacteria resistant to penicillin. In addition to treating tuberculosis, streptomycin was effective against typhoid fever, cholera, bubonic plague and other diseases. Among the other antibiotics isolated in Waksman's laboratory was neomycin, still used as a topical antibacterial agent.

William F. Carroll, Ph.D., president of the Society, will present a commemorative bronze plaque to Tim Casey, Ph.D., Dean of Academic and Student Programs at Cook College, Rutgers University. H. Boyd Woodruff, Ph.D., who isolated the first two actinomycete antibiotics, will be the featured speaker. The award presentation takes place in conjunction with the ACS Middle Atlantic Regional Meeting. The MARM meeting is being held on the nearby Busch Campus of Rutgers in Piscataway, New Jersey, May 22-25.


'"/>

Source:Rutgers University


Page: 1 2

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. Research advances quest for HIV-1 vaccine
6. Research on Worms Yields Clues on Aging
7. Researchers reveal the infectious impact of salmon farms on wild salmon
8. Researchers identify target for cancer drugs
9. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism

Post Your Comments:
(Date:11/25/2009)...ens, Ga. Bacteria don,t have easy lives. In addit...ugs, they have natural enemies called bacteriophag...very two days. , Still, bacteria and another cl...ered in extreme environments such as deep-sea volc...ecause they have a built-in defense system that he...
(Date:11/25/2009)...r. Sarit Larisch, Head of the Cell Death Research ... of Biology, has been awarded the prestigious John...ch exploring the cause of brain cell damage in Par... year to scientists in support of innovation and e...fficially conferred earlier this month at an event...
(Date:11/25/2009)...r the course of a lifetime, the heart pumps some 2...e order to do this, the muscle fibers of the heart...headed by Dr. Wolfgang Rottbauer, vice chair of th...ity Hospital (Chairman: Prof. Dr. H. A. Katus), ha... stability of the smallest muscular unit, the sarc...
Breaking Biology News(10 mins):Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2Halos of Hope ASTRO partner to raise awareness of cancer survivorship 59519 1 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 1 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 2 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 3Biomedical Research Centre searches for immunological biomarkers 59513 1Biomedical Research Centre searches for immunological biomarkers 59513 2
...hs of a vaccine designed to fight avian influenza ...enter. , The Duke study is part of a multicenter t...ational bird flu vaccine to determine whether the ... lower doses. , The seven-month trial is sponsor...ious Diseases of the National Institutes of Health...
...al Center study shows that exposure to environment... associated with behavior problems in children and...r olds with asthma, the findings most likely could...a who "act out" or experience depression and anxie...her at the Children,s Environmental Health Center ...
... aggressive, but may keep them that way into young...here may be other, lasting consequences for the de...uary,s Behavioral Neuroscience, also showed that a...itter levels in the brain,s aggression control reg...American Psychological Association (APA). , Neuros...
Other Biology News:Duke to test bird flu vaccine dosing 2Environmental tobacco smoke linked to behavior problems in children and pre-teens 2Animal models show that anabolic steroids flip the adolescent brain's switch for aggression 2Animal models show that anabolic steroids flip the adolescent brain's switch for aggression 3
(Date:11/24/2009)...REYKJAVIK,Iceland,November24/PRNewswire-FirstCall/...dtheapprovalofallofits,"firstday"motionsbytheU.S.B...ptcyCourt").deCODElastweekfiledavoluntarypetitionf...Codewiththe,BankruptcyCourt. , Theordersissue...perateitsbusinessduringtheChapter11proceedings.Inp...
(Date:11/24/2009)...SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neur...yfocusedondevelopingandcommercializingnovelpainman...PresidentandChiefExecutiveOfficer,isscheduledtopre...e,tobeheldDecember1-2,2009atTheNewYorkPalaceHoteli...eri,ChiefFinancialOfficer,willbeavailabletorespond...
(Date:11/24/2009)...SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.a...opmentAuthority(OPDA)wererecentlyawarded$2millionb...oard(CERB)inaprivate/publicpartnershiptoconstructt...colnCounty,WA. ,, "Thisinvestmentwillsignifican...70greenjobstoLincolnCounty,"saidBlueMarbleEnergyCE...
(Date:11/24/2009)...Primaryefficacyendpointhasbeenmetforpatientswithad...QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZen...obalbiopharmaceuticalcompanyfocusedonendocrinether...romaPhase2studywithitstargetedcytotoxicpeptideconj...cedorrecurrentendometrialcancer.Inapersonalizedhea...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...rve Pharmaceutical Partner Interest for ...., March 31 Transgenomic, Inc. (OTC,Bulletin Boar...ompany,today announced that it has entered into a ...amily Planning Center in Guangzhou, China. Under t...Guangzhou Laboratory to,provide pharmacogenomic an...
...n Medical, Inc., the,leading developer of stents d...n lesions announced today that it has closed a $14...stors, PTV Sciences and RiverVest Venture,Partners...ng. Rick Anderson,from PTV and Jay Schmelter from ...of Directors., "Bifurcation lesions are an import...
...peutics, a drug,and diagnostic discovery company, ... Jaskowiak will join the Management Board on April...l become President of the,Management Board, until ...rved as CFO of ExonHit Therapeutics since 2002,and...004. John Jaskowiak,who joined ExonHit in 2006, wa...
Other Biology Technology:Transgenomic Opens Pharmacogenomics Laboratory in China 2Transgenomic Opens Pharmacogenomics Laboratory in China 3Tryton Medical, Inc. Closes $14 Million Financing 2Tryton Medical, Inc. Closes $14 Million Financing 3ExonHit Appoints a New Management Board 2ExonHit Appoints a New Management Board 3ExonHit Appoints a New Management Board 4
...apid-Screen cDNA Library Panels were designed for ...ts of PCRs to identify the desired cDNA clone. The...ter Plate," where each well contains plasmid DNA f...ell(s) by gel electrophoresis of the reaction prod...
...A Jobin Yvons Protein 295 ex can measure three flu...otein sample in only a few minutes. To match the a...ryptophan, the Protein 295 exs excitation source i... 295 nm. Fluorescence of tryptophan is widely used...
...arrays designed for proteomic scale kinase profili...ivities, and drug discovery research built on the ... synthesis platform. These microarrays are availab...strate - Peptide Microarray Service. Probe Conte...
...-7000 is a research grade spectrofluorometer which...dth and scanning speeds of up to 60,000nm/min. It...oncentrated light beam along with low sample volum...C fluorescence applications software, which offers...
Biology Products: